GAS5 and neoplasm: Finally, prediction models incorporating GAS5 loss resulted in superior stratification specificity and improved positive prediction of NMIBC patients’ poor survival outcome following tumour resection, offering a significantly higher clinical benefit for patients’ prognosis and monitoring compared to models of the established and clinically used prognostic markers alone.